Radient Pharmaceuticals Corporation
2492 Walnut Avenue
Suite 100
Tustin,
CA 92780-6953
United States - Map
Phone: 714-505-4461
Fax: 714-505-4464
Web Site: http://www.radient-pharma.com
| Radient Pharmaceuticals Corporation engages in the development, manufacture, distribution, and sale of medical diagnostic products, generic pharmaceuticals, nutritional supplements, and cosmetics. It offers Onko-Sure, a non-invasive cancer blood test to detect lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, and pancreatic cancer; and Elleuxe, a therapeutic skin care product line based on the active ingredient Elleuxe Protein that offers cell renewing properties designed to minimize the appearance of aging. The company also involves in the manufacture and distribution of generic and homeopathic pharmaceutical products and supplements, as well as cosmetic products. In addition, Radient Pharmaceuticals Corporation owns a cancer vaccine combination immunogene therapy technology that intends to build the bodys immune system and destroy cancer cells. The company sells its products directly to hospitals, laboratories, and retail stores, as well as indirectly to other customers through distributors primarily in the United States, Canada, China, Chile, Europe, India, Korea, Taiwan, and Vietnam. It has a collaboration agreement with Mayo Clinic. The company was formerly known as AMDL, Inc. and changed its name to Radient Pharmaceuticals Corporation on September 25, 2009. Radient Pharmaceuticals Corporation was founded in 1988 and is based in Tustin, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Douglas C. MacLellan , 54
Chairman, Chief Exec. Officer and Pres |
$
255.00K | N/A | Frank Zheng ,
Exec. Officer |
$
445.00K | N/A | Mr. Akio Ariura , 51
Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer and Sec. |
N/A
| N/A | Kristine Szarkowitz ,
Director of Investor Relations |
N/A
| N/A | Mr. Christopher Gee , 47
Director of International Marketing and Sales |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.02% Nasdaq 
0.33%
Profile
